Bio
In 2008 Sander S. Florman travelled from his home in New Orleans to Mount Sinai — where here had trained — to celebrate the 20th anniversary of Mount Sinai's Liver Transplant Program. Now he directs Mount Sinai’s organ transplantation program.
One year later, Dr. Florman is back—this time as the new Director of Mount Sinai Recanati/Miller Transplantation Institute, one of a total of 14 translational research institutes that are at the heart of Icahn School of Medicine at Mount Sinai's Strategic Plan. The Institute bears the name of Dr. Florman's mentor, Charles M. Miller, MD.
"Mount Sinai is where I got my start," says Dr. Florman. "I stood on the shoulders of giants here, so it is incredibly rewarding to return and take up a leadership position and work with so many familiar faces. It will be a fantastic team."
"It is very rewarding to be reunited with Dr. Florman," says Dr. Schwartz. "For more than 20 years, RMountI has led the field of organ transplantation, and now we are going to work hard to lay the foundation for the next 20 years. Working with the Transplantation Institute allows us to capitalize on the synergy between hepatobiliary surgery and liver transplantation to solidify Mount Sinai as one of the premier liver transplant centers in the United States and to restore our program's preeminence in living donor liver transplantation. We have recruited a great leader in Dr. Florman."
"Sandy makes everyone around him better and gets people to work as a team— the mark of a great leader. He has vision, he inspires people to do better than they think they can, and he is able to bring the team together for a common purpose—and that's what he's going to bring to Mount Sinai." Michael L. Marin, MD, the Dr. Julius H. Jacobson II Chair in Vascular Surgery, Professor and Chairman of the Department of Surgery, readily agrees. "Mount Sinai is very fortunate to have Sandy Florman back. He is a gifted surgeon with a true passion for transplantation, and he knows exactly how to bring the best out of his team.
One year later, Dr. Florman is back—this time as the new Director of Mount Sinai Recanati/Miller Transplantation Institute, one of a total of 14 translational research institutes that are at the heart of Icahn School of Medicine at Mount Sinai's Strategic Plan. The Institute bears the name of Dr. Florman's mentor, Charles M. Miller, MD.
"Mount Sinai is where I got my start," says Dr. Florman. "I stood on the shoulders of giants here, so it is incredibly rewarding to return and take up a leadership position and work with so many familiar faces. It will be a fantastic team."
"It is very rewarding to be reunited with Dr. Florman," says Dr. Schwartz. "For more than 20 years, RMountI has led the field of organ transplantation, and now we are going to work hard to lay the foundation for the next 20 years. Working with the Transplantation Institute allows us to capitalize on the synergy between hepatobiliary surgery and liver transplantation to solidify Mount Sinai as one of the premier liver transplant centers in the United States and to restore our program's preeminence in living donor liver transplantation. We have recruited a great leader in Dr. Florman."
"Sandy makes everyone around him better and gets people to work as a team— the mark of a great leader. He has vision, he inspires people to do better than they think they can, and he is able to bring the team together for a common purpose—and that's what he's going to bring to Mount Sinai." Michael L. Marin, MD, the Dr. Julius H. Jacobson II Chair in Vascular Surgery, Professor and Chairman of the Department of Surgery, readily agrees. "Mount Sinai is very fortunate to have Sandy Florman back. He is a gifted surgeon with a true passion for transplantation, and he knows exactly how to bring the best out of his team.
